The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Options Update: Sepracor volatility low into product pipeline setbacks

 Jul 02, 2009 02:00 PM UTC
Return Risk
+0.00% N/A
Tracked Blogger
Symbol Sentiment Start Return Closed
SEPR n/a

Graphic_arrow1 Via BloggingStocks:  

Filed under: Options

Sepracor (NASDAQ: SEPR) is recently down $2.89 to $15 in pre-open trading. SEPR announced that SEP-225289 failed to meet its primary endpoint in a pivotal Phase 2 trial in patients with major depressive disorder. SEPR also announced the FDA has put two Lunesta pediatric studies on hold due to concerns about non-clinical data that could be relevant to the use of Lunesta in children. SEPR over all option implied volatility of 48 is below its 26-week average of 57, according to Track Data, suggesting decreasing price movement.


NASDAQ 100 - QQQQ overall implied volatility at 26; 26-week average is 33.


Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Options Update: Sepracor volatility low into product pipeline setbacks originally appeared on BloggingStocks on Thu, 02 Jul 2009 09:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati



 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch